Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes.
Mika T, Strate K, Ladigan S, Aigner C, Schlegel U, Tischoff I, Tischer-Zimmermann S, Eiz-Vesper B, Maecker-Kolhoff B, Schroers R. Mika T, et al. Among authors: aigner c. Front Med (Lausanne). 2019 Dec 18;6:295. doi: 10.3389/fmed.2019.00295. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31921871 Free PMC article.
Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK.
Hegedüs L, Padányi R, Molnár J, Pászty K, Varga K, Kenessey I, Sárközy E, Wolf M, Grusch M, Hegyi Z, Homolya L, Aigner C, Garay T, Hegedüs B, Tímár J, Kállay E, Enyedi Á. Hegedüs L, et al. Among authors: aigner c. Front Oncol. 2017 May 24;7:95. doi: 10.3389/fonc.2017.00095. eCollection 2017. Front Oncol. 2017. PMID: 28596940 Free PMC article.
Lung Cancer Surgery after Neoadjuvant Immunotherapy.
Stefani D, Plönes T, Viehof J, Darwiche K, Stuschke M, Schuler M, Aigner C. Stefani D, et al. Among authors: aigner c. Cancers (Basel). 2021 Aug 10;13(16):4033. doi: 10.3390/cancers13164033. Cancers (Basel). 2021. PMID: 34439187 Free PMC article. Review.
Nintedanib and Dasatinib Treatments Induce Protective Autophagy as a Potential Resistance Mechanism in MPM Cells.
Hegedüs L, Szücs KD, Kudla M, Heidenreich J, Jendrossek V, Peña-Llopis S, Garay T, Czirok A, Aigner C, Plönes T, Vega-Rubin-de-Celis S, Hegedüs B. Hegedüs L, et al. Among authors: aigner c. Front Cell Dev Biol. 2022 Mar 22;10:852812. doi: 10.3389/fcell.2022.852812. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35392170 Free PMC article.
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial.
Schuler M, Cuppens K, Plönes T, Wiesweg M, Du Pont B, Hegedus B, Köster J, Mairinger F, Darwiche K, Paschen A, Maes B, Vanbockrijck M, Lähnemann D, Zhao F, Hautzel H, Theegarten D, Hartemink K, Reis H, Baas P, Schramm A, Aigner C. Schuler M, et al. Among authors: aigner c. Nat Med. 2024 Jun;30(6):1602-1611. doi: 10.1038/s41591-024-02965-0. Epub 2024 Apr 30. Nat Med. 2024. PMID: 38689060 Free PMC article. Clinical Trial.
COVID-19 in a lung transplant recipient.
Aigner C, Dittmer U, Kamler M, Collaud S, Taube C. Aigner C, et al. J Heart Lung Transplant. 2020 Jun;39(6):610-611. doi: 10.1016/j.healun.2020.04.004. Epub 2020 Apr 13. J Heart Lung Transplant. 2020. PMID: 32340870 Free PMC article. Review. No abstract available.
The vascular nature of lung-resident mesenchymal stem cells.
Steens J, Klar L, Hansel C, Slama A, Hager T, Jendrossek V, Aigner C, Klein D. Steens J, et al. Among authors: aigner c. Stem Cells Transl Med. 2021 Jan;10(1):128-143. doi: 10.1002/sctm.20-0191. Epub 2020 Aug 24. Stem Cells Transl Med. 2021. PMID: 32830458 Free PMC article.
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial.
Guberina M, Eberhardt W, Stuschke M, Gauler T, Aigner C, Schuler M, Stamatis G, Theegarten D, Jentzen W, Herrmann K, Pöttgen C. Guberina M, et al. Among authors: aigner c. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1439-1447. doi: 10.1007/s00259-019-4270-x. Epub 2019 Feb 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 30710323 Clinical Trial.
367 results